Background: G protein-coupled receptor 35 (GPR35) is involved in carcinogenesis; however, limited experimental data are available on its actual expression in patients with colorectal cancer (CRC) and pancreatic adenocarcinoma (PDAC).
Objectives: We aimed to measure the relative expression of GPR35 in samples from patients with CRC or PDAC.
Material And Methods: Using real-time polymerase chain reaction (RT-PCR), we have examined GPR35 expression in surgery samples from 40 CRC and 17 PDAC patients, and performed analysis of the results.
Results: The analysis of GPR35 expression in patients with CRC revealed correlations between relative GPR35 mRNA expression and several tumor characteristics, with statistical significance for higher American Joint Committee on Cancer (AJCC) stages, T stages and histological grades. GPR35 expression was significantly higher in tumor samples compared to the paired healthy samples collected from the same patient. Similar, although not statistically significant trends were found in PDAC tumor samples for sex (lower expression in women) and for samples with no nodal involvement (lower expression). Samples with higher tumor T stages and higher histological grades or considered inoperable had higher GPR35 expression.
Conclusions: We have identified correlations which confirm our expectation of high GPR35 expression in CRC and PDAC. Our findings suggest the prognostic value of GPR35 testing in patients with an increased risk of CRC or PDAC development, and warrant further clinical confirmation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17219/acem/157291 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Investigating the Role of TRPV4 and GPR35 Interaction in Endothelial Dysfunction in Aging Mice.
Aging Cell
January 2025
Wuxi School of Medicine, Jiangnan University, Wuxi, China.
Endothelial dysfunction, characterized by a decline in endothelial physiological functions, is a significant aspect of cardiovascular aging, contributing notably to arterial stiffness, atherosclerosis, and hypertension. Transient receptor potential channel V4 (TRPV4), a key member of Ca-permeable channels, plays a crucial role in maintaining vascular functions. However, the role and mechanisms of TRPV4 in aging-related endothelial dysfunction remain incompletely understood.
View Article and Find Full Text PDFBiased constitutive signaling of the G protein-coupled receptor GPR35 suppresses gut barrier permeability.
J Biol Chem
November 2024
Centre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address:
Article Synopsis
- Constitutive activity of G protein-coupled receptors, like GPR35, plays a key role in maintaining the integrity of the epithelial barrier in the gut, which is crucial for preventing inflammatory diseases.
- Studies showed that certain inverse agonists could disrupt this barrier function in colonic organoids, suggesting the importance of GPR35's ongoing, or "constitutive," activation.
- The research found that the activity of GPR35 varies depending on the specific signaling pathways and levels of receptor expression, highlighting its complex role in cellular responses and potential therapeutic implications for inflammatory bowel conditions.
GPR35 agonists inhibit TRPA1-mediated colonic nociception through suppression of substance P release.
Pain
October 2024
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom.
The development of nonopioid analgesics for the treatment of abdominal pain is a pressing clinical problem. To address this, we examined the expression of Gi/o-coupled receptors, which typically inhibit nociceptor activation, in colonic sensory neurons. This led to the identification of the orphan receptor GPR35 as a visceral analgesic drug target because of its marked coexpression with transient receptor potential ankyrin 1 (TRPA1), a mediator of noxious mechanotransduction in the bowel.
View Article and Find Full Text PDFThe Complex World of Kynurenic Acid: Reflections on Biological Issues and Therapeutic Strategy.
Int J Mol Sci
August 2024
The Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Oxford OX3 7FY, UK.
It has been unequivocally established that kynurenic acid has a number of actions in a variety of cells and tissues, raising, in principle, the possibility of targeting its generation, metabolism or sites of action to manipulate those effects to a beneficial therapeutic end. However, many basic aspects of the biology of kynurenic acid remain unclear, potentially leading to some confusion and misinterpretations of data. They include questions of the source, generation, targets, enzyme expression, endogenous concentrations and sites of action.
View Article and Find Full Text PDFRole of orphan G-protein coupled receptors in tissue ischemia: A comprehensive review.
Eur J Pharmacol
September 2024
Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address:
Ischemic events lead to many diseases and deaths worldwide. Ischemia/reperfusion (I/R) occurs due to reduced blood circulation in tissues followed by blood reflow. Reoxygenation of ischemic tissues is characterized by oxidative stress, inflammation, energy distress, and endoplasmic reticulum stress.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!